1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Vital Signs - The Analyst's Perspective - March 2015 Issue

Vital Signs - The Analyst's Perspective - March 2015 Issue

  • April 2015
  • -
  • Frost & Sullivan
  • -
  • 7 pages

This issue of Vital Signs, released on April 3, 2015, discusses next-generation sequencing bioinformatics partnerships, FDA approval of Novartis's ZARXIO, 23andMe's foray into drug development, and Johnson & Johnson's sale of Cordis to Cardinal Health.

NGS Bioinformatics Partnerships Heat Up

Source: Cartagenia and Tute Genomics, March 17, 2015
On March 17, two announcements emerged concerning next-generation sequencing (NGS) informatics companies teaming up to provide complete workflows. DNAnexus and Tute Genomics joined forces, while Cartegenia and N-of-One will integrate their offerings as well. DNAnexus and Tute Genomics have teamed up to provide an integrated solution for upstream primary analyses and downstream interpretation along the NGS bioinformatics workflow. DNAnexus, based in Mountain View, Calif., provides a configurable cloud-based platform for storage, computing, and NGS primary and secondary data analysis. Tute Genomics, based in Provo, Utah, provides a cloud-based solution for genome annotation and clinical interpretation and reporting.

The combined offering streamlines data transfer between the two offerings so end users can easily transfer variant data from DNAnexus to Tute’s platform for downstream analysis. Cartegnia, based in Cambridge, Mass., offers its Bench Lab NGS platform, which manages NGS data, performs variant calling, and puts variants into patient-related information and phenotypic context. N-of-One provides clinical interpretation services of NGS data. The combined offering is aimed at pathology labs, allowing them to
integrate N-of-One’s genomic and tumor intreprations into their Bench Lab NGS platforms.

Table Of Contents

Vital Signs - The Analyst's Perspective - March 2015 Issue
LIFE SCIENCES
NGS Bioinformatics Partnerships Heat Up . 2
Who Wins with Recent FDA Approval of Novartis's ZARXIO Biosimilar?. 3
In Big Shift, 23andMe will Invent Drugs Using Customer Data. 4
JandJ Sells Cordis to Cardinal: A Worthy Investment?. 6

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Genome Editing/Genome Engineering Market by Technology, Applications, End User - Global Forecast to 2021

Genome Editing/Genome Engineering Market by Technology, Applications, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing ...

Biochip Market Analysis by Type, Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), by End Use, and Segment Forecasts to 2024

Biochip Market Analysis by Type, Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), by End Use, and Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

Global biochips anticipated market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements ...

Global Lab Automation in Genomics Market Segmented by Type of Equipment, Software, Analyzers, Plate Readers and Geography Forecasts, Shares and Trends (2016 - 2021)

Global Lab Automation in Genomics Market Segmented by Type of Equipment, Software, Analyzers, Plate Readers and Geography Forecasts, Shares and Trends (2016 - 2021)

  • $ 4250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The emergence of robotics has transformed the typical workday for scientists around the world. With the advent of automation techniques, scientists are now able to set up, run and analyze the results of ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.